Translational considerations for cancer nanomedicine

Particle size-dependent organ distribution of gold nanoparticles after intravenous administration

Wim H. de Jong, Werner I. Hagens, Petra Krystek et al. · Biomaterials · 2008 · 1.6K citations

Pharmacy, Pharmaceutics, Pharmacokinetics +16

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Emil J. Freireich, E. A. Gehan, David P. Rall et al. · PubMed · 1966 · 1.4K citations

Pharmacy, Oncology, Toxicology +14

Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology

Günter Oberdörster · Journal of Internal Medicine · 2009 · 930 citations · Full text

Pharmacy, Pharmacokinetics, Toxicology +17

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

J I Johnson, Shannon Decker, Daniel Zaharevitz et al. · British Journal of Cancer · 2001 · 858 citations · Full text

Medicine, Oncology, Pharmacology +14

Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property:  Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor Efficacy

Younsoo Bae, Nobuhiro Nishiyama, Shigeto Fukushima et al. · Bioconjugate Chemistry · 2004 · 732 citations

Pharmacy, Pharmaceutics, Pharmacology +17